The portfolio consists of formulations which have specifically been developed for a broad range of applications. Properties of foamed injection molded parts SPECIAL FOAMING PROCESSES A number of specific processes have been developed to achieve special properties of the foamed parts. Avient makes no warranties or guarantees respecting suitability of either Avient’s products or the information for your process or end-use application.

Avient can help you apply integrated anti-counterfeiting solutions to your polymer articles with our specialty additives and technical support.

New Black Colorants from Avient turn former waste into recyclable packaging

These polymer formulations have been developed to achieve equivalent performance to prime density modified solutions with added sustainability benefits. Avient makes no warranties or guarantees respecting suitability of either Avient’s products or the information for your process or end-use application. AVIENT MAKES NO WARRANTIES, EXPRESS OR IMPLIED, INCLUDING, BUT NOT LIMITED TO, IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE, either with respect to the information or products reflected by the information.

The Cesa F-Series of FR additives are non- halogenated materials developed to pass strict test methods, providing excellent UL 94 compliance and successfully meeting UL 2335 and FM4998 standards. PE Control Conventional FR Cesa F-Series 1 Cesa F-Series 2 Time, Seconds H ea t R el ea se R at e kW /m 2 2000 1500 1000 500 0 1.844.4AVIENT www.avient.com Copyright © 2024, Avient Corporation. Avient makes no warranties or guarantees respecting suitability of either Avient’s products or the information for your process or end-use application.

Vitamins A, B2 (riboflavin), D and amino acids become lost, lipids (milk fats) oxidize, and off-flavors can develop due to the resulting decomposition products. Avient makes no warranties or guarantees respecting suitability of either Avient’s products or the information for your process or end-use application. AVIENT MAKES NO WARRANTIES, EXPRESS OR IMPLIED, INCLUDING, BUT NOT LIMITED TO, IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE, either with respect to the information or products reflected by the information.

Consider these solutions: • Anti-stat to prevent dust build up • UV blockers or stabilizers to protect package contents • Anti-microbials for limiting microbe development • Scratch and mar technology to preserve surface finishes • Impact modifiers that increase flexibility and durability Reduce Risk with Regulatory Support We know that regulatory compliance requirements are constantly changing. Avient makes no warranties or guarantees respecting suitability of either Avient’s products or the information for your process or end-use application. AVIENT MAKES NO WARRANTIES, EXPRESS OR IMPLIED, INCLUDING, BUT NOT LIMITED TO, IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE, either with respect to the information or products reflected by the information.

Packaging The Hydrocerol CFAs portfolio includes grades specially developed for extruded packaging films and sheets where thermoforming characteristics of the finished article are critical. APPLICATIONS 1.844.4AVIENT www.avient.com Copyright © 2024, Avient Corporation. Avient makes no warranties or guarantees respecting suitability of either Avient’s products or the information for your process or end-use application.

AVIENT CORPORATION COMPENSATION COMMITTEE CHARTER Membership • The Committee will consist entirely of directors who meet the definition of “independent” as set forth in the Corporate Governance Standards of the New York Stock Exchange, including the additional independence requirements set forth in New York Stock Exchange Listed Company Manual Section 303A.02(a)(ii). • Members of the Committee will be appointed by the Board each year. • Each Committee member will serve at the pleasure of the Board for such term as the Board may decide or until such Committee member is no longer a Board member. • The Committee shall consist of a minimum of three directors. Evaluation of the Chief Executive Officer. • Develop and maintain a process to enable the Board to evaluate the performance of the Chief Executive Officer on an annual basis and timely communicate the results of any such evaluation to the Chief Executive Officer. Independence Assessment of Outside Advisers • The Committee may select a compensation consultant, legal counsel or other adviser to the Committee or receive advice from a compensation consultant, legal counsel or other adviser (other than in-house legal counsel or any compensation consultant, legal counsel or other adviser whose role is limited to the following activities for which no disclosure would be required under Item 407(e)(3)(iii) of Regulation S-K: consulting on any broad-based plan that does not discriminate in scope, terms, or operation, in favor of executive officers or directors of the Company, and that is available generally to all salaried employees; or providing information that either is not customized for a particular company or that is customized based on parameters that are not developed by the compensation consultant, and about which the compensation consultant does not provide advice) only after taking into consideration all factors relevant to that person’s independence from management, including the following: 5 • the provision of other services to the Company by the employer of the compensation consultant, legal counsel or other adviser; • the amount of fees received from the Company by the employer of the compensation consultant, legal counsel or other adviser, as a percentage of the total revenue of the employer of the compensation consultant, legal counsel or other adviser; • the policies and procedures of the employer of the compensation consultant, legal counsel or other adviser that are designed to prevent conflicts of interest; • any business or personal relationship of the compensation consultant, legal counsel or other adviser with a member of the Committee; • any stock of the Company owned by the compensation consultant, legal counsel or other adviser; and • any business or personal relationship of the compensation consultant, legal counsel, other adviser or the employer of the adviser with an executive officer of the Company. • The Committee shall evaluate whether any compensation consultant retained or to be retained by it has any conflict of interest in accordance with Item 407(e)(3)(iv) of Regulation S-K.